Immunochemicals

Immunochemicals

Global Immunochemicals Market to Reach US$7.1 Billion by 2030

The global market for Immunochemicals estimated at US$5.0 Billion in the year 2023, is expected to reach US$7.1 Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2023-2030. Catalog Antibodies, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.6 Billion by the end of the analysis period. Growth in the Custom Antibodies segment is estimated at 6.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 5.0% CAGR

The Immunochemicals market in the U.S. is estimated at US$1.3 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 5.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Global Immunochemical Market - Key Trends and Drivers Summarized

Immunochemicals are crucial tools in the field of biomedical research, diagnostics, and therapeutic applications. The increasing prevalence of chronic diseases worldwide, such as cancer and autoimmune disorders, necessitates advanced diagnostic and therapeutic solutions, bolstering the demand for high-quality immunochemicals. Additionally, the expanding focus on personalized medicine emphasizes the need for specific immunochemicals to develop tailored treatments based on individual genetic and immunological profiles. As researchers gain a deeper understanding of the immune system`s complexities, there is an increased need for these chemicals in research, particularly for applications in drug discovery and the customization of medical treatments.

Technological advancements in immunoassay technologies, such as enhanced ELISA methods, flow cytometry, and mass spectrometry, are broadening the applications of immunochemicals in clinical diagnostics and research. These improvements, along with increased automation in laboratories, are optimizing the sensitivity, specificity, and throughput of assays, leading to more efficient and accurate immunochemical-based tests. The growth of the biotechnology and pharmaceutical industries, especially in emerging markets, further fuels the demand for immunochemicals. This is supported by heightened investments in healthcare infrastructure and research and development activities, increasing the production and innovation in biopharmaceuticals.

The therapeutic antibodies market is seeing a surge in growth due to their efficacy in treating a range of diseases, propelling further research and demand for innovative immunochemicals. Monoclonal antibodies, in particular, have transformed treatments for diseases such as cancer and autoimmune disorders. Alongside this, increased funding for immunology research from both government and private sectors is enhancing the development of new immunochemicals and technologies. This financial support, combined with a supportive regulatory environment and strong intellectual property rights, is encouraging further investment and innovation in the sector, promising continued advancements and applications of immunochemicals in healthcare.

Select Competitors (Total 116 Featured) -

• Abcam Plc.
• Agilent Research Laboratories
• Beckman Coulter GmbH
• Biolegend Inc.
• Bio-Rad Laboratories Inc.
• Cell Signaling Technology Inc.
• GenScript Biotech Corporation
• PerkinElmer Inc.
• Rockland Immunochemicals Inc.
• Santa Cruz Biotechnology Inc.
• Sigma-Aldrich Corporation
• Thermo Fischer Scientific Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.